cells Review Two Sides of the Coin: Mast Cells as a Key Regulator of Allergy and Acute/Chronic Inflammation Zhongwei Zhang 1 and Yosuke Kurashima 1,2,3,4,5,* 1 Department of Innovative Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan;
[email protected] 2 Department of Mucosal Immunology, The University of Tokyo Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan 3 International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan 4 CU-UCSD Center for Mucosal Immunology, Department of Pathology/Medicine, Allergy and Vaccines, University of California, San Diego, CA 92093-0063, USA 5 Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan * Correspondence:
[email protected]; Tel.: +81-43-226-2848; Fax: +81-43-226-2183 Abstract: It is well known that mast cells (MCs) initiate type I allergic reactions and inflammation in a quick response to the various stimulants, including—but not limited to—allergens, pathogen- associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs). MCs highly express receptors of these ligands and proteases (e.g., tryptase, chymase) and cytokines (TNF), and other granular components (e.g., histamine and serotonin) and aggravate the allergic reaction and inflammation. On the other hand, accumulated evidence has revealed that MCs also possess immune-regulatory functions, suppressing chronic inflammation and allergic reactions on Citation: Zhang, Z.; Kurashima, Y. some occasions. IL-2 and IL-10 released from MCs inhibit excessive immune responses.